In contrast, a 1 SD increase in the polygenic score for adult height, corresponding to an approximately 1.7 cm increase in adult height attainment, was associated with decreased risk of MYCN‐amplified neuroblastoma in both case‐control (OR = 0.87, P = .047) and case‐case (MYCN‐amplified vs MYCN‐unamplified) analyses (OR = 0.85, P = .028; Table 1). Here, MYCN is linked to neuroblastoma.